Skip to Main Content

Author Details

Simion I Chiosea
University of Pittsburgh
2003
145
48
PMIDPaper TitleJournal TitlePublished Year
37475109Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK).Pigment Cell Melanoma Res2024
36272768Association of comprehensive thyroid cancer molecular profiling with tumor phenotype and cancer-specific outcomes.Surgery2023
37071871Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management.J Clin Endocrinol Metab2023
36746884NKX3.1 Expression and Molecular Characterization of Secretory Myoepithelial Carcinoma (SMCA): Advancing the Case for a Salivary Mucous Acinar Phenotype.Head Neck Pathol2023
36525543Sebaceous Differentiation as Another Feature of Metatypical Adenoid Cystic Carcinoma: A Case Report and Letter to the Editor.Am J Surg Pathol2023
35876443Clinicopathologic Characteristics and Postsurgical Follow-Up of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in the Postnomenclature Revision Era.Thyroid2022
35734044Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis.Laryngoscope Investig Otolaryngol2022
35864811Performance of a Multigene Genomic Classifier in Thyroid Nodules with Suspicious for Malignancy Cytology.Thyroid2022
32809265Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma.Cancer Cytopathol2021
33830464RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma.Head Neck Pathol2021
33792557Molecular alterations in Hürthle cell nodules and preoperative cancer risk.Endocr Relat Cancer2021
33487086Clinicopathologic Characteristics of Thyroid Nodules Positive for the <i>THADA-IGF2BP3</i> Fusion on Preoperative Molecular Analysis.Thyroid2021
33901345Impact of molecular testing on detecting mimics of oncocytic neoplasms in thyroid fine-needle aspirates diagnosed as follicular neoplasm of Hürthle cell (oncocytic) type.Cancer Cytopathol2021
33929681SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications.Head Neck Pathol2021
34091485Mucoacinar Carcinoma: A Rare Variant of Mucoepidermoid Carcinoma.Am J Surg Pathol2021
34083421Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial.J Immunother Cancer2021
33428064Primary and Secondary/ Metastatic Salivary Duct Carcinoma Presenting within the Sinonasal Tract.Head Neck Pathol2021
33236834Alternate diagnostic test interpretation in a retrospective convenience cohort and clinical application of MPTX.Diagn Cytopathol2021
30840224Hamartoma of the Oral Cavity with Ectopic Meningothelial Elements in Infants: A Rare Entity with Report of Two Cases.Head Neck Pathol2020
31918174The role of adjuvant (chemo-)radiotherapy in oral cancers in the contemporary era.Oral Oncol2020
31917707Histologic Classification and Molecular Signature of Polymorphous Adenocarcinoma (PAC) and Cribriform Adenocarcinoma of Salivary Gland (CASG): An International Interobserver Study.Am J Surg Pathol2020
32415114Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers.Sci Rep2020
32329958Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experience.Head Neck2020
32124417Intraoperative Margin Assessment in Head and Neck Cancer: A Case of Misuse and Abuse?Head Neck Pathol2020
29700721Measuring Depth of Invasion in Early Squamous Cell Carcinoma of the Oral Tongue: Positive Deep Margin, Extratumoral Perineural Invasion, and Other Challenges.Head Neck Pathol2019
31349395On challenges of disproving inferiority of tumor bed margins.Oral Dis2019
31174238Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: A model predicting local control and vetting of the eighth edition of the American Joint Committee on Cancer pathologic T stage.Cancer2019
31539879Characterization of thyroid cancer driven by known and novel ALK fusions.Endocr Relat Cancer2019
30843621Genomic analysis of recurrences and high-grade forms of polymorphous adenocarcinoma.Histopathology2019
30683736Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancer.J Exp Med2019
30520817The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland.Am J Surg Pathol2019
30648929GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland.Thyroid2019
30419129Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.JAMA Oncol2019
29135520Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.Am J Surg Pathol2018
30419840Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.BMC Cancer2018
30299546Patients with revised surgical resection margins are best studied as a distinct group.Cancer2018
29443014Recurrent RET Gene Rearrangements in Intraductal Carcinomas of Salivary Gland.Am J Surg Pathol2018
29596555Standardized Margin Assessment Is Needed Before Implementing Negative Margin as a Quality Measure.JAMA Otolaryngol Head Neck Surg2018
29076874Clear Cell Carcinoma of Salivary Glands Is Frequently p16 Positive: A Pitfall in the Interpretation of Oropharyngeal Biopsies.Am J Surg Pathol2018
27681332Template for Reporting Results of Biomarker Testing of Specimens From Patients With Thyroid Carcinoma.Arch Pathol Lab Med2017
28463429HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.Histopathology2017
28193878<i>THADA</i> fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer.Proc Natl Acad Sci U S A2017
28352657Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer.JCI Insight2017
28450437Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.AJNR Am J Neuroradiol2017
28125451Clinical and Morphologic Features of ETV6-NTRK3 Translocated Papillary Thyroid Carcinoma in an Adult Population Without Radiation Exposure.Am J Surg Pathol2017
28153128Intraoperative Margin Assessment in Early Oral Squamous Cell Carcinoma.Surg Pathol Clin2017
28098136Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.Nat Commun2017
28493366Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.J Pathol2017
28291122SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.Am J Surg Pathol2017
28370646Retracted: Worst Pattern Of Invasion and occult cervical metastases for oral squamous carcinoma.Head Neck2017
  • 1 - 50 of 145

Recommended Authors

David Geffen School of Medicine University of California Los Angeles California USA.
Career Start Year 2016
Number of shared co-authors 6
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2015
Number of shared co-authors 2
Southern Illinois University School of Medicine
Career Start Year 2013
Number of shared co-authors 3
Western University
Career Start Year 2009
Number of shared co-authors 5
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 3
New York-Presbyterian Hospital-Weill Cornell Medical College
Career Start Year 2008
Number of shared co-authors 1
Royal Prince Alfred Hospital
Career Start Year 2007
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 18
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 9
University of Tokyo
Career Start Year 2005
Number of shared co-authors 2
Jewish General Hospital
Career Start Year 2004
Number of shared co-authors 4
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 7
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 4
University of Toronto
Career Start Year 2003
Number of shared co-authors 5
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 17
The University of Texas M. D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 15
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 13
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 24
Walter Reed National Military Medical Center
Career Start Year 1997
Number of shared co-authors 4
Hospital of the University of Pennsylvania
Career Start Year 1995
Number of shared co-authors 1
University of Chicago Pritzker School of Medicine
Career Start Year 1993
Number of shared co-authors 8
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 7
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 20
University of Michigan ann arbor
Career Start Year 1989
Number of shared co-authors 19
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 14
Stanford University School of Medicine
Career Start Year 1988
Number of shared co-authors 4
Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 8
Memorial Sloan Kettering Cancer Center
Career Start Year 1984
Number of shared co-authors 39
University of California
Career Start Year 1977
Number of shared co-authors 10
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 16

Collaborators

University of Pittsburgh Medical Center-Presbyterian
Co-authored papers 55
University of Pittsburgh School of Medicine
Co-authored papers 19
University of California san francisco
Co-authored papers 18
Woodland Hills Medical Center
Co-authored papers 17
George Washington University
Co-authored papers 12
Virginia Mason Hospital and Seattle Medical Center
Co-authored papers 9
University Health Network
Co-authored papers 9
Co-authored papers 7
UT Southwestern Medical Center
Co-authored papers 7
Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College
Co-authored papers 6
University Health Network
Co-authored papers 5
University of Virginia Medical Center
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 5
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Co-authored papers 4
Co-authored papers 4
Memorial Sloan-Kettering Cancer Center
Co-authored papers 3
Icahn School of Medicine at Mount Sinai Hospital.
Co-authored papers 3
University of California san francisco
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Charles University
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 2
University of Pittsburgh
Co-authored papers 2
Ontario Cancer Institute, University Health Network (UHN)
Co-authored papers 2
Novartis Institutes for BioMedical Research
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 2
Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 2
Co-authored papers 2
Broad Institute of Harvard and MIT
Co-authored papers 2